MY NGUYEN: Open Payments
NPI 1093488967 · JACKSONVILLE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$656 in 39 payments from 11 companies in 2025. Trend: 2023 $216 · 2024 $825 · 2025 $656
Food & beverage: $656
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 17 | $254 |
| Lilly USA, LLC | 6 | $110 |
| AstraZeneca Pharmaceuticals LP | 4 | $69 |
| Amgen Inc. | 3 | $54 |
| PFIZER INC. | 2 | $42 |
| ABBVIE INC. | 2 | $32 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $22 |
| Merck Sharp & Dohme LLC | 1 | $21 |
| SANOFI PASTEUR INC. | 1 | $20 |
| GlaxoSmithKline, LLC. | 1 | $16 |
Products named: Wegovy, MOUNJARO, OTEZLA, Ozempic, Rybelsus, AIRSUPRA, QULIPTA, ELIQUIS.
Industry payments across FL — which companies pay providers there.
